De novo design of antiviral monobody binders

Monobodies (Mobs) are a class of immunoglobulin (Ig)-like proteins that have emerged as promising therapeutic scaffolds for applications ranging from antiviral therapy to cancer treatment. Unlike conventional monoclonal antibodies (mAbs), Mobs can be readily expressed in Escherichia coli at high yields, offering important advantages in overall developability. However, discovering antigen-specific Mobs with high binding affinity traditionally requires screening large, randomized in vitro libraries. To optimize Mob discovery, we developed MobGen, a computational pipeline for de novo design of Mob binders against viral antigens. As a proof of concept, we generated Mobs that bind the SARS-CoV-2 Spike glycoprotein Receptor Binding Domain (RBD). Subsequent in silico optimization improved production yield, thermal and conformational stability, binding affinity, and antiviral activity, demonstrating a promising approach for rapidly developing antibody-like molecules that target viral entry. These findings highlight MobGen's potential for de novo design of Mobs against emerging viruses with pandemic potential.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-16
DOI
https://doi.org/10.64898/2026.11.12.760042
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

De novo design of antiviral monobody binders

José Valpuesta, Javier Collado, Miguel A. R. B. Castanho, María Jesús Rodríguez-Espinosa et al.
1 links
bioRxiv (Cold Spring Harbor Laboratory)
Monoclonal and Polyclonal Antibodies Research
preprint

De novo design of antiviral monobody binders

José Valpuesta, Javier Collado, Miguel A. R. B. Castanho, María Jesús Rodríguez-Espinosa, Joseph H. Schmidt, Ana Salomé Veiga, Cláudio M. Soares, Beatriz Vieira‐da‐Silva, Marta Pires de Miranda, Carlota J.F. Conceição, Carolina C. Buga, Christine Cruz-Oliveira, João B. Vicente, Maria João Amorim, César A. Santiago, Rocío Arranz, Sandrine Georgeon, Diana Lousa, Marta Alenquer, Pedro Moreira, Isabel Alexandra Abreu, Shuhao Xiao, Haiyang Yu, Diogo H.P. Silva, Correia, Bruno, E, Mariana Parada, Jéssica Rodrigues, Madalena C. Marques
preprint en

Abstract

Monobodies (Mobs) are a class of immunoglobulin (Ig)-like proteins that have emerged as promising therapeutic scaffolds for applications ranging from antiviral therapy to cancer treatment. Unlike conventional monoclonal antibodies (mAbs), Mobs can be readily expressed in Escherichia coli at high yields, offering important advantages in overall developability. However, discovering antigen-specific Mobs with high binding affinity traditionally requires screening large, randomized in vitro libraries. To optimize Mob discovery, we developed MobGen, a computational pipeline for de novo design of Mob binders against viral antigens. As a proof of concept, we generated Mobs that bind the SARS-CoV-2 Spike glycoprotein Receptor Binding Domain (RBD). Subsequent in silico optimization improved production yield, thermal and conformational stability, binding affinity, and antiviral activity, demonstrating a promising approach for rapidly developing antibody-like molecules that target viral entry. These findings highlight MobGen's potential for de novo design of Mobs against emerging viruses with pandemic potential.

bioRxiv (Cold Spring Harbor Laboratory)
City University of Hong Kong (HK), Universidade Católica Portuguesa (PT), Centro Nacional de Biotecnología (ES), Gulbenkian Institute for Molecular Medicine (PT), Instituto de Tecnologia Química e Biológica António Xavier (PT), Instituto Gulbenkian de Ciência (PT), École Polytechnique Fédérale de Lausanne (CH), Universidade Nova de Lisboa (PT)
European Commission, National Institutes of Health, HORIZON EUROPE Framework Programme, Fundação para a Ciência e a Tecnologia, National Institute of Allergy and Infectious Diseases, NextGenerationEU
Good health and well-being
Monoclonal and Polyclonal Antibodies Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon